From hydroxychloroquine to ivermectin: how unproven "cures" can go viral.
作者信息
Taccone Fabio Silvio, Hites Maya, Dauby Nicolas
机构信息
Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Department of Infectious Disease, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
出版信息
Clin Microbiol Infect. 2022 Apr;28(4):472-474. doi: 10.1016/j.cmi.2022.01.008. Epub 2022 Feb 3.
Abstract
摘要
相似文献
1
From hydroxychloroquine to ivermectin: how unproven "cures" can go viral.从羟氯喹到伊维菌素：未经证实的“疗法”是如何迅速传播的。
Clin Microbiol Infect. 2022 Apr;28(4):472-474. doi: 10.1016/j.cmi.2022.01.008. Epub 2022 Feb 3.
2
COVID-19: Panama stockpiles unproven drugs.
Nature. 2020 Nov;587(7835):548. doi: 10.1038/d41586-020-03289-y.
3
Management of crash and burn patients with SARS-CoV-2 associated ARDS.新型冠状病毒肺炎相关急性呼吸窘迫综合征（SARS-CoV-2 associated ARDS）重症患者的管理
J Card Surg. 2020 Sep;35(9):2129-2130. doi: 10.1111/jocs.14699. Epub 2020 Jul 14.
4
Pharmaceutical messianism and the politics of COVID-19 in the United States.医药救世主主义与美国的 COVID-19 政治。
Glob Public Health. 2024 Jan;19(1):2350656. doi: 10.1080/17441692.2024.2350656. Epub 2024 May 8.
5
Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study.伊维菌素在预防印度医护人员感染 SARS-CoV-2 中的作用：一项匹配病例对照研究。
PLoS One. 2021 Feb 16;16(2):e0247163. doi: 10.1371/journal.pone.0247163. eCollection 2021.
6
Outpatient purchasing patterns of hydroxychloroquine and ivermectin in the USA and Canada during the COVID-19 pandemic: an interrupted time series analysis from 2016 to 2021.美国和加拿大 COVID-19 大流行期间羟氯喹和伊维菌素的门诊购买模式：2016 年至 2021 年的中断时间序列分析。
J Antimicrob Chemother. 2022 Dec 23;78(1):242-251. doi: 10.1093/jac/dkac382.
7
Rise of the preprint: how rapid data sharing during COVID-19 has changed science forever.预印本的兴起：新冠疫情期间的快速数据共享如何永远改变了科学。
Nat Med. 2022 Jan;28(1):2-5. doi: 10.1038/s41591-021-01654-6.
8
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.羟氯喹预防 COVID-19 的集群随机试验。
N Engl J Med. 2021 Feb 4;384(5):417-427. doi: 10.1056/NEJMoa2021801. Epub 2020 Nov 24.
9
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?羟氯喹作为 COVID-19 的预防或治疗药物：证据说了什么？
Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20.
10
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
引用本文的文献
1
Translational Success and Pharmacoeconomic Lessons of Pandemic-Driven Drug Repurposing.大流行驱动的药物重新利用的转化成功与药物经济学经验教训。
Cureus. 2025 May 29;17(5):e85033. doi: 10.7759/cureus.85033. eCollection 2025 May.
2
Mismanagement of SARS-CoV-2 Infection Pre Hospitalisation during the Omicron Era: Antibiotics and Steroids Instead of Early Antivirals.奥密克戎时代下，对 SARS-CoV-2 感染住院前管理的失误：抗生素和类固醇，而非早期抗病毒药物。
Viruses. 2024 Jun 22;16(7):1005. doi: 10.3390/v16071005.
3
Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study.新冠肺炎临床试验注册信息传播度（DIRECCT）：一项横断面研究。
BMC Med. 2023 Nov 29;21(1):475. doi: 10.1186/s12916-023-03161-6.
4
A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?一个关于错误信息的曲折故事：伊维菌素是否应被批准用于治疗新冠疾病？
Future Virol. 2023 Feb. doi: 10.2217/fvl-2023-0006. Epub 2023 Mar 9.
5
A mixed methods study exploring requests for unproven COVID therapies such as ivermectin and healthcare distrust in the rural South.一项混合方法研究，探讨在南方农村地区对伊维菌素等未经证实的新冠治疗方法的需求以及对医疗保健的不信任。
Prev Med Rep. 2023 Feb;31:102104. doi: 10.1016/j.pmedr.2022.102104. Epub 2022 Dec 31.
6
Patients With Schizophrenia-Spectrum Disorders as Vulnerable Populations in an Age of Misinformation: A Case Report of Ivermectin-Related Liver Failure.
J Acad Consult Liaison Psychiatry. 2022 Nov-Dec;63(6):639-640. doi: 10.1016/j.jaclp.2022.08.004.
7
The COVID misinfodemic: not new, never more lethal.新冠错误信息泛滥：由来已久，从未如此致命。
Trends Microbiol. 2022 Oct;30(10):948-958. doi: 10.1016/j.tim.2022.07.004. Epub 2022 Aug 6.
Zotero 插件